Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From anatomy to vulnerability: A comprehensive appraisal of coronary physiology and plaque characterization.

American heart journal plus : cardiology research and practice·2026
Same author

The effectiveness of a real-world smoking cessation clinic: A prospective cohort study.

Tobacco induced diseases·2026
Same author

Tumour-Derived Extracellular Vesicles Induce Diffuse Large B-Cell Lymphoma Progression Through Macrophage-Mediated MDSC Accumulation.

Journal of extracellular vesicles·2026
Same author

<i>In vivo</i> circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone.

Bioactive materials·2026
Same author

Mitochondrial micro-nano reactors via enhancing mitochondrial transfer and mitophagy for alleviating metabolic crisis.

Bioactive materials·2026
Same author

Reconstructing protein conformations to activate follicular enzyme-nutrient reservoirs for reversing follicle aging.

Bioactive materials·2026

Related Experiment Video

Updated: Jun 27, 2025

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

2.6K

Progress in Procalcitonin Detection Based on Immunoassay.

Jiayue Huang1, Yan Zu2, Lexiang Zhang2,3

  • 1State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

Research (Washington, D.C.)
|May 7, 2024
PubMed
Summary
This summary is machine-generated.

Emerging immunoassay technologies offer improved procalcitonin (PCT) detection for clinical needs. These advancements promise enhanced precision and real-time monitoring for sepsis diagnosis and infection management.

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.7K

Related Experiment Videos

Last Updated: Jun 27, 2025

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

2.6K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.7K

Area of Science:

  • Biochemistry
  • Clinical Diagnostics
  • Biomarker Analysis

Background:

  • Procalcitonin (PCT) is a vital biomarker for sepsis diagnosis and infection severity assessment.
  • Current PCT detection methods lack the accuracy and real-time capabilities required for optimal clinical application.
  • Effective PCT monitoring is crucial for guiding antimicrobial therapy and theranostic strategies.

Purpose of the Study:

  • To review emerging procalcitonin immunoassay technologies.
  • To analyze the advantages of novel methods in improving detection performance, including ease of use and precision.
  • To discuss the clinical significance of PCT detection and the performance parameters of various assays.

Main Methods:

  • Overview of established PCT immunoassay principles: chemiluminescence, immunofluorescence, latex-enhanced turbidity, ELISA, colloidal gold immunochromatography, and radioimmunoassay.
  • Introduction to advanced techniques incorporating responsive nanomaterials, Raman spectroscopy, and digital microfluidics.
  • Analysis of detection performance metrics and clinical relevance.

Main Results:

  • Emerging PCT immunoassay technologies demonstrate potential for enhanced detection performance.
  • Novel methods offer improvements in operational simplicity and quantitative precision.
  • Integration with advanced materials and technologies like nanomaterials and microfluidics shows promise for future diagnostics.

Conclusions:

  • New PCT immunoassay technologies are crucial for addressing limitations in current clinical diagnostics.
  • These advancements are expected to improve real-time monitoring and accuracy in infection management.
  • Further development and validation of these methods will enhance their clinical utility in diagnosing and managing infections.